TNXP Operating Cash Flow (Statement)

Tonix Pharmaceuticals Holding Corp · Operating Cash Flow (Statement)

TNXP logo

TNXP Operating Cash Flow (Statement)

Latest reported-$154.72M
TNXP TTM Cash from Operations (-$23.57K → -$154.72M)
High-resolution chart · PNG

TNXP operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Tonix Pharmaceuticals Holding Corp Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-154,720,398
-127,310,398
-101,571,398
-76,551,398
-64,843,000
-59,929,000
-60,925,000
-68,635,000
-73,219,000
-86,667,000
-102,003,000
-102,428,601
-102,578,601
-100,382,601
-98,517,601
-98,197,000
-87,608,000
-85,545,000
-75,557,000
-67,026,000
-69,365,000
-60,298,000
-48,566,000
-41,366,000
-32,695,000
-27,370,000
-26,683,000
-26,793,000
-25,070,000
-25,839,000
-23,971,000
-22,074,000
-22,230,000
-21,105,000
-19,128,000
-19,644,000
-22,989,000
-26,624,000
-37,315,000
-43,784,000
-47,717,000
-48,960,000
-42,528,000
-38,834,000
-31,368,000
-27,829,000
-22,840,000
-18,153,049
-16,156,942
-11,219,371
-8,517,000
-6,491,191
-4,928,495
-5,296,879
-5,712,864
-6,840,743
-6,099,055
-5,200,657
-3,803,992
-1,180,328
-623,864
-394,434
-19,982
-12,795
-13,363
-25,302
-27,869
-30,542
-32,769
-23,587
-23,568
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.